C0035171||Novel Strategy
C0022688||Super-Charged NK Cells
C0024348||Lyse
C1956422||Cancer Stem Cells
C0007595||NK Expansion
C1708335||Healthy
C0022688||Natural killer (NK) cells
C1956422||cancer stem cells
C0205698||undifferentiated tumors
C0035171||novel strategy
C0022688||super-charged NK cells
C0024348||lyse
C1956422||cancer stem cells
C0022688||NK cell
C0007595||expansion
C0013018||healthy donors
C1849420||Decline in cytotoxicity
C0441994||lower
C3156720||interferon (IFN)-γ secretion
C0029431||osteoclast
C0029431||osteoclast
C0022688||NK cells
C0007595||expansion
C0039194||T cells
C0022688||NK cells
C0013018||healthy donors
C0029431||OCs
C0022688||super-charged NK cells
C0039194||T cell
C0007595||expansion
C0022688||NK cells
C0022688||NK cells
C0027651||tumor
C2986594||BLT-humanized mice
C0007595||expansion
C2673541||T cells resulting in decreased numbers
C0022688||NK cells
C0022688||NK cells
C0025929||mice
C1513916||no
C0027651||tumor
C0007595||expanding
C0022688||NK cells
C0596402||cytotoxicity
C0011306||dendritic cells
C0011306||dendritic cells
C0029431||OCs
C0007595||expansion
C0039194||T cells
C0022688||NK cells
C2363838||decline in NK cell numbers
C1708335||healthy individuals
C3831520||anti-CD3 mAb
C1155046||T cell proliferation
C0022688||NK cell
C0007595||expansion
C0007595||expanding
C0022688||NK cells
C0441994||lower
C0596402||cytotoxicity
C3156720||secretion of IFN-γ
C0007595||Expansion
C0022688||super-charged NK cells
C0029431||OCs
C0123759||interleukin (IL)-12
C0254610||IL-15
C0035171||novel strategy
C0007595||expand
C0022688||super-charged NK cells
C0007595||rapid and sustained expansion
C0039194||T cells
C0022688||NK cells
C0007595||expansion
C0011306||dendritic cells
C0029431||OCs
C2363838||NK cells decline
C2986594||BLT-humanized mice